Gainers

• ShiftPixy, Inc. PIXY shares surged 176.5% to shut at $31.00 on Thursday after the corporate introduced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.
• Amylyx Prescription drugs, Inc. AMLX gained 51% to settle at $27.03 after the FDA Advisory Committee voted that accessible proof of effectiveness is enough to assist approval of AMX0035 for the therapy of ALS. Citigroup and SVB Leerink raised their worth targets.
• Rubius Therapeutics, Inc. RUBY climbed 48.6% to shut at $1.29 after declining 11% on Wednesday. Rubius Therapeutics, final month, posted a Q2 lack of $0.49 per share.
• Benitec Biopharma Inc. BNTC shares gained 33% to shut at $0.7880. The corporate, final week, filed its annual report on Type 10-Ok for the quarter ended June 30, 2022, with the U.S. Securities and Trade Fee.
• Marker Therapeutics, Inc. MRKR rose 31.5% to shut at $0.3999 after the corporate’s Section 2 examine of multi-tumor-associated antigen-specific T cell remedy for relapsed/refractory AML appeared on the FDA’s Orphan Merchandise Grants Program website.
• Palatin Applied sciences, Inc. PTN gained 26.2% to shut at $6.31 after the corporate introduced the initiation of affected person recruitment for its Section 2 examine evaluating oral PL8177 in ulcerative colitis.
• LifeStance Well being Group, Inc. LFST jumped 25.8% to shut at $9.57. LifeStance Well being named Ken Burdick as CEO and Chairman.
• T Stamp Inc. IDAI gained 25% to settle at $1.85.
• Asana, Inc. ASAN shares gained 24.8% to shut at $23.76 after the corporate reported better-than-expected outcomes for its second quarter and issued a robust gross sales steering. RBC Capital and Citigroup raised their worth targets on the inventory.
• Relay Therapeutics, Inc. RLAY gained 23.8% to shut at $31.37. Relay Therapeutics introduced efficacy of RLY-4008, a extremely selective FGFR2 inhibitor in sufferers with a FGFR2-fusion or rearrangement FGFR inhibitor-naïve cholangiocarcinoma: ReFocus trial.
• Revance Therapeutics, Inc. RVNC gained 21.6% to shut at $25.30 after the corporate introduced FDA approval of DAXXIFY for injection for non permanent enchancment of reasonable to extreme frown traces.
• SPAR Group, Inc. SGRP rose 21.3% to shut at $1.54 after the corporate’s board of administrators initiated a course of to guage potential strategic alternate options together with a sale, merger or different strategic transaction.
• Allarity Therapeutics, Inc. ALLR rose 20.4% to settle at $1.30.
• Eve Holding, Inc. EVEX jumped 20% to shut at $7.39. United reported a $15 million funding in Eve Air Mobility and a conditional buy settlement for 200 four-seat electrical plane plus 200 choices.
• Regeneron Prescription drugs, Inc. REGN climbed 18.9% to settle at $708.85 after the corporate introduced that the first endpoints have been met in two pivotal trials investigating novel aflibercept 8 mg with 12- and 16-week dosing regimens in sufferers with diabetic macular edema and moist age-related macular degeneration.
• Eyenovia, Inc. EYEN gained 18.6% to shut at $2.48.
• VistaGen Therapeutics, Inc. VTGN jumped 18.4% to shut at $0.1953 after the corporate introduced the completion of an interim evaluation of its PALISADE-2 Section 3 medical trial of PH94B.
• IVERIC bio, Inc. ISEE gained 18.3% to settle at $17.68 after Stifel maintained a Purchase ranking on the inventory and raised its worth goal from $28 to $35.
• First Excessive-College Training Group Co., Ltd. FHS gained 17% to shut at $0.75.
• Lyft, Inc. LYFT gained 16.9% to shut at $17.17 amid imprecise rumors from a questionable supply mentioning the corporate.
• NantHealth, Inc. NH jumped 16.4% to shut at $0.4788.
• Venus Idea Inc. VERO gained 15.8% to shut at $0.7473.
• Annovis Bio, Inc. ANVS climbed 15.7% to settle at $12.19 after HC Wainwright & Co initiated protection on the inventory with a Purchase ranking and introduced a $40 worth goal.
• Phreesia, Inc. PHR rose 15.6% to shut at $27.64 after the corporate reported better-than-expected Q2 gross sales outcomes and raised the low-end of its FY23 gross sales steering.
• Tandem Diabetes Care, Inc. TNDM jumped 15.3% to shut at $52.61.
• AeroVironment, Inc. AVAV gained 14.9% to shut at $101.87 after reporting upbeat quarterly gross sales.
• Immunocore Holdings plc IMCR rose 14.9% to settle at $57.44 after Ladenburg Thalmann initiated protection on the inventory with a Purchase ranking and introduced an $82 worth goal.
• Terns Prescription drugs, Inc. TERN gained 14.7% to shut at $4.36.
• Rhythm Prescription drugs, Inc. RYTM rose 14.4% to shut at $23.86. Rhythm Prescription drugs introduced new employment inducement grants. Goldman Sachs maintained Rhythm Prescription drugs with a Purchase and raised the value goal from $28 to $31.
• Cazoo Group Ltd CZOO gained 13.5% to shut at $0.6921. The corporate introduced it can wind down operations in mainland Europe to deal with core UK market.
• PROCEPT BioRobotics Company PRCT jumped 11.3% to shut at $49.93.
• Rivian Automotive, Inc. RIVN gained 10.9% to shut at $36.88 after the corporate and Mercedes-Benz Vans signed a Memorandum of Understanding for a strategic partnership.
• John Wiley & Sons, Inc. WLY gained 10.8% to settle at $46.08. CJS Securities upgraded John Wiley & Sons from Market Carry out to Market Outperform.
• Allego N.V. ALLG rose 9.6% to shut at $4.33. Allego not too long ago introduced first half monetary outcomes and 2022 income expectations.
• Heliogen, Inc. HLGN rose 9.5% to shut at $2.42.
• Albireo Pharma, Inc. ALBO surged 9.4% to shut at $18.23. Guggenheim initiated protection on Albireo Pharma with a Purchase ranking and introduced a worth goal of $55.
• Snap Inc. SNAP rose 9.3% to shut at $12.53 on continued energy after a current inner memo obtained by The Verge advised the corporate is aiming to succeed in $6 billion in income and 450 million customers by subsequent 12 months.
• Intapp, Inc. INTA rose 8.5% to shut at $15.95 after the corporate reported better-than-expected This autumn outcomes and issued steering above estimates.
• GameStop Corp. GME rose 7.5% to shut at $25.83 after the corporate reported better-than-expected earnings for its second quarter and in addition introduced a partnership with cryptocurrency alternate FTX to convey extra prospects to the digital asset area.
• Zillow Group, Inc. ZG gained 6.3% to shut at $37.58 after Jefferies maintained a Purchase ranking on the inventory and raised its worth goal from $48 to $50.

Losers

• Troika Media Group, Inc. TRKA dipped 26.8% to settle at $0.4756 on Thursday after declining round 6% on Wednesday.
• Nice Panther Mining Restricted GPL shares tumbled 25.9% to shut at $0.2396. The corporate not too long ago introduced it has decided to file a discover of intention to make a proposal beneath the Chapter and Insolvency Act, which can present credit score safety.
• PlayAGS, Inc. AGS shares fell 20.2% to shut at $6.07.
• Ensysce Biosciences, Inc. ENSC fell 19.7% to shut at $0.3313.
• a.ok.a. Manufacturers Holding Corp. AKA dipped 19.2% to shut at $2.36.
• Globalstar, Inc. GSAT fell 18.9% to settle at $1.67 amid attainable revenue taking. The inventory gained on Wednesday after the corporate introduced it is going to be the satellite tv for pc operator for Apple satellite-enabled companies.
• Biophytis S.A. BPTS declined 17.7% to shut at $0.9139. Biophytis not too long ago introduced top-line outcomes from its part 2-3 COVA medical examine evaluating Sarconeos within the therapy of COVID-19-related respiratory failure.
• Golden Path Acquisition Company GPCO fell 16.7% to shut at $7.40.
• VirnetX Holding Corp VHC dipped 16.6% to shut at $1.56.
• Addentax Group Corp. ATXG dropped 15.7% to settle at $5.22.
• Shuttle Prescription drugs Holdings, Inc. SHPH fell 15.5% to shut at $30.76.
• Nogin, Inc. NOGN declined 15.4% to shut at $1.71.
• Bilibili Inc. BILI fell 15% to shut at $20.07 following Q2 outcomes.
• Skillsoft Corp. SKIL fell 14.9% to shut at $2.29 after the corporate posted downbeat quarterly gross sales and licensed a $30 million share buyback.
• Tandy Leather-based Manufacturing facility Inc. TLF fell 14.8% to shut at $5.24 following uplisting of its inventory.
• Dave & Buster’s Leisure, Inc. PLAY dropped 14.2% to shut at $37.72. Whereas the corporate reported better-than-expected Q2 outcomes, working earnings dropped from 2021 ranges.
• Innovid Corp. CTV fell 13.9% to shut at $3.17.
• Genenta Science S.p.A. GNTA fell 13.5% to shut at $4.60.
• Chembio Diagnostics, Inc. CEMI shares fell 13% to shut at $0.5449. Chembio Diagnostics filed for potential inventory providing.
• Cohn Robbins Holdings Corp. CRHC dipped 12.8% to shut at $7.96.
• MasterCraft Boat Holdings, Inc. MCFT fell 12.7% to shut at $20.74. The corporate posted upbeat quarterly earnings, however issued weak FY23 forecast. MasterCraft Boat additionally bought its NauticStar enterprise to Iconic Marine Group.
• Mercer Worldwide Inc. MERC dipped 12.5% to shut at $14.07.
• The Lovesac Firm LOVE dropped 12.4% to shut at $26.18 following Q2 outcomes.
• Erasca, Inc. ERAS fell 11.3% to shut at $8.34. Erasca introduced preliminary Section 1/1b monotherapy knowledge for ERK1/2 inhibitor ERAS-007 and SHP2 inhibitor ERAS-601 in BRAF-driven and RAS/MAPK-altered stable tumors.
• Sylvamo Company SLVM declined 9.8% to shut at $36.50.
• Sabre Company SABR dropped 9.5% to shut at $6.54 after Mizuho maintained a Impartial ranking on the inventory and lowered its worth goal from $8 to $7.
• Mullen Automotive, Inc. MULN fell 9.3% to shut at $0.61 after the corporate introduced it has acquired a 60% controlling curiosity in Bollinger Motors for $148.2 million in money and inventory.
• American Eagle Outfitters, Inc. AEO shares fell 8.7% to settle at $10.58 after the corporate reported worse-than-expected Q2 EPS outcomes.
• McCormick & Firm, Integrated MKC fell 6.7% to shut at $79.30. McCormick mentioned it expects third-quarter FY22 gross sales to extend about 3% year-on-year and 6% in fixed forex.
• Wayfair Inc. W fell 3.7% to shut at $48.81 after the corporate reported a proposed providing of $600 million convertible senior notes.
• Grid Dynamics Holdings, Inc. GDYN fell 3.6% to shut at $19.08 after the corporate priced its frequent inventory providing of about 5.71 million shares at $17.50 per share.